Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

USAQQHSLab, Inc.

OTC · CIK 0000856984
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC3841 Surgical & Medical Instruments & Apparatus
FY end1231
XBRL facts202

Identity from submissions API

NameQHSLab, Inc.
CIK0000856984
TickersUSAQ
ExchangesOTC
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC3841 Surgical & Medical Instruments & Apparatus
EIN112655906
LEI—
Fiscal year end1231
State of incorporationNV NV
Phone(929) 379-6503
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • USA EQUITIES CORP. (2015-11-23T05:00:00.000Z → 2022-04-19T04:00:00.000Z)
  • AMERICAN BIOGENETIC SCIENCES INC (1996-05-14T04:00:00.000Z → 2015-11-16T05:00:00.000Z)
Business address
901 NORTHPOINT PARKWAY
SUITE 302
WEST PALM BEACH
FL
33407
FL
Mailing address
901 NORTHPOINT PARKWAY
SUITE 302
WEST PALM BEACH
FL
33407
FL

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

361 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-12 10-Q 10-Q 0001493152-26-051468 000-19041 261547973 34 4133400 1 1
2026-09-17 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002154811-26-000001 005-45379 261386143 34 10348
2026-09-10 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002154816-26-000001 005-45379 261372484 34 11653
2026-09-04 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0002130246-26-000004 005-45379 261361960 34 10240
2026-09-03 4 PRIMARY DOCUMENT 0002130246-26-000003 5667
2026-08-12 10-Q 10-Q 0001493152-26-037255 000-19041 261265440 34 3977279 1 1
2026-08-03 8-K 8-K 7.01,9.01 0001493152-26-035749 000-19041 261230551 34 362329 1 1
2026-06-17 8-K 8-K 7.01,9.01 0001493152-26-029053 000-19041 261097386 34 21472255 1 1
2026-05-26 8-K 8-K 7.01,9.01 0001493152-26-025170 000-19041 261016035 34 237192 1 1
2026-05-14 10-Q 10-Q 0001493152-26-022888 000-19041 26975988 34 3979341 1 1
2026-04-29 3 PRIMARY DOCUMENT 0002130246-26-000002 4551
2026-04-27 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0002130246-26-000001 005-45379 26900486 34 12791
2026-04-21 8-K 8-K 7.01,9.01 0001493152-26-018222 000-19041 26876939 34 265274 1 1
2026-03-31 8-K 8-K 7.01,9.01 0001493152-26-013836 000-19041 26817221 34 243288 1 1
2026-03-30 10-K 10-K 0001493152-26-013513 000-19041 26810623 34 4948109 1 1
2026-02-25 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-26-008008 005-45379 26676665 34 6702
2026-02-24 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-26-007898 005-45379 26672590 34 6657
2026-02-13 5 5 0001493152-26-006728 10801
2026-01-26 8-K 8-K 7.01,9.01 0001493152-26-003526 000-19041 26558465 34 235468 1 1
2026-01-23 8-K 8-K 1.01,3.02,8.01,9.01 0001493152-26-003438 000-19041 26557461 34 1458282 1 1
2026-01-16 8-K 8-K 7.01,9.01 0001493152-26-002496 000-19041 26537672 34 231461 1 1
2026-01-06 D xslFormDX01/primary_doc.xml 06b 0001493152-26-000529 021-569009 26509660 33 6444
2026-01-06 8-K 8-K 7.01,9.01 0001493152-26-000527 000-19041 26509654 34 262560 1 1
2026-01-02 8-K 8-K 1.01,3.02,9.01 0001493152-26-000092 000-19041 26501994 34 1488252 1 1
2025-12-29 8-K 8-K 1.01,3.02,7.01,9.01 0001493152-25-029222 000-19041 251603354 34 439356 1 1
2025-12-03 8-K 8-K 7.01,9.01 0001493152-25-025892 000-19041 251545064 34 280615 1 1
2025-12-01 8-K 8-K 7.01,9.01 0001493152-25-025495 000-19041 251537269 34 5601618 1 1
2025-11-24 8-K 8-K 7.01,9.01 0001493152-25-024758 000-19041 251509621 34 233040 1 1
2025-11-18 8-K 8-K 1.01,2.04,7.01,9.01 0001493152-25-023990 000-19041 251492884 34 3159235 1 1
2025-11-13 10-Q 10-Q 0001493152-25-022138 000-19041 251475714 34 3868399 1 1
2025-09-02 8-K 8-K 7.01,9.01 0001641172-25-026187 000-19041 251284272 34 235653 1 1
2025-08-14 10-Q 10-Q 0001641172-25-023737 000-19041 251214583 34 3903201 1 1
2025-07-08 8-K 8-K 7.01,9.01 0001641172-25-018099 000-19041 251109586 34 271473 1 1
2025-06-03 8-K 8-K 7.01,9.01 0001641172-25-013369 000-19041 251017230 34 258413 1 1
2025-05-21 8-K 8-K 7.01,9.01 0001641172-25-011926 000-19041 25973737 34 58325245 1 1
2025-05-16 8-K 8-K 7.01,9.01 0001641172-25-011175 000-19041 25956973 34 234834 1 1
2025-05-15 8-K 8-K 7.01,9.01 0001641172-25-010495 000-19041 25948595 34 268952 1 1
2025-05-14 10-Q 10-Q 0001641172-25-010300 000-19041 25946246 34 3738907 1 1
2025-03-28 10-K form10-k.htm 0001641172-25-001230 000-19041 25787093 34 4531213 1 1
2025-02-26 8-K form8-k.htm 7.01,9.01 0001493152-25-008278 000-19041 25666280 34 237139 1 1
2025-02-25 8-K form8-k.htm 2.04,9.01 0001493152-25-008228 000-19041 25664536 34 214362 1 1
2025-02-18 8-K form8-k.htm 7.01,9.01 0001493152-25-007093 000-19041 25632849 34 272400 1 1
2025-02-11 8-K form8-k.htm 7.01,9.01 0001493152-25-005807 000-19041 25607846 34 266270 1 1
2025-01-21 8-K form8-k.htm 7.01,9.01 0001493152-25-002939 000-19041 25540533 34 15000317 1 1
2025-01-16 8-K form8-k.htm 7.01,9.01 0001493152-25-002469 000-19041 25534334 34 2954010 1 1
2024-12-16 8-K form8-k.htm 7.01,9.01 0001493152-24-050120 000-19041 241550205 34 264010 1 1
2024-12-13 8-K form8-k.htm 7.01,9.01 0001493152-24-049905 000-19041 241546886 34 247202 1 1
2024-11-25 8-K form8-k.htm 7.01,9.01 0001493152-24-047553 000-19041 241492086 34 280757 1 1
2024-11-14 8-K form8-k.htm 7.01,9.01 0001493152-24-045361 000-19041 241457340 34 270826 1 1
2024-11-13 10-Q form10-q.htm 0001493152-24-045058 000-19041 241453144 34 3844366 1 1
2024-10-22 8-K form8-k.htm 1.01,3.02,7.01,9.01 0001493152-24-041891 000-19041 241384749 34 10596031 1 1
2024-10-21 8-K form8-k.htm 7.01,9.01 0001493152-24-041717 000-19041 241382091 34 248182 1 1
2024-09-25 8-K form8-k.htm 7.01,9.01 0001493152-24-038060 000-19041 241321495 34 353417 1 1
2024-09-17 8-K form8-k.htm 7.01,9.01 0001493152-24-036548 000-19041 241302694 34 265019 1 1
2024-08-14 8-K forn8-k.htm 7.01,9.01 0001493152-24-031937 000-19041 241204620 34 261534 1 1
2024-08-14 10-Q form10q.htm 0001493152-24-031878 000-19041 241204248 34 3754535 1 1
2024-06-07 8-K form8-k.htm 4.01,9.01 0001493152-24-023142 000-19041 241030423 34 219041 1 1
2024-05-13 8-K form8-k.htm 7.01,9.01 0001493152-24-018806 000-19041 24937101 34 255988 1 1
2024-05-13 10-Q form10-q.htm 0001493152-24-018786 000-19041 24936940 34 3467642 1 1
2024-05-02 8-K form8-k.htm 7.01,9.01 0001493152-24-017490 000-19041 24905480 34 242572 1 1
2024-04-26 8-K form8-k.htm 7.01,9.01 0001493152-24-016061 000-19041 24878990 34 235352 1 1
2024-04-18 8-K form8-k.htm 7.01,9.01 0001493152-24-015159 000-19041 24853789 34 13536651 1 1
2024-03-28 8-K form8-k.htm 7.01,9.01 0001493152-24-011611 000-19041 24793607 34 246256 1 1
2024-03-27 10-K form10-k.htm 0001493152-24-011551 000-19041 24792004 34 4309655 1 1
2024-01-30 8-K form8-k.htm 7.01,9.01 0001493152-24-004238 000-19041 24575954 34 299901 1 1
2023-11-13 10-Q form10-q.htm 0001493152-23-040470 000-19041 231398394 34 3929074 1 1
2023-10-25 8-K form8-k.htm 7.01,9.01 0001493152-23-038204 000-19041 231344140 34 14901142 1 1
2023-10-18 8-K form8-k.htm 7.01,9.01 0001493152-23-037562 000-19041 231330941 34 239647 1 1
2023-10-06 8-K form8-k.htm 1.01,9.01 0001493152-23-036453 000-19041 231313013 34 206382 1 1
2023-08-10 10-Q form10-q.htm 0001493152-23-027470 000-19041 231157514 34 3870975 1 1
2023-05-15 8-K form8-k.htm 7.01,9.01 0001493152-23-016920 000-19041 23918483 34 253466 1 1
2023-05-12 10-Q form10-q.htm 0001493152-23-016675 000-19041 23916347 34 3515015 1 1
2023-03-29 10-K form10-k.htm 0001493152-23-009477 000-19041 23775619 34 4409338 1 1
2023-02-16 8-K form8-k.htm 7.01,9.01 0001493152-23-005276 000-19041 23637227 34 238462 1 1
2023-01-30 8-K form8-k.htm 7.01,9.01 0001493152-23-002859 000-19041 23565337 34 249213 1 1
2022-11-14 8-K form8-k.htm 7.01,9.01 0001493152-22-031652 000-19041 221380608 34 254571 1 1
2022-11-14 10-Q form10-q.htm 0001493152-22-031462 000-19041 221379283 34 4306691 1 1
2022-11-01 8-K form8-k.htm 7.01,9.01 0001493152-22-030065 000-19041 221348596 34 246098 1 1
2022-10-07 424B3 form424b3.htm 0001493152-22-027865 333-267627 221299241 33 1096676
2022-10-05 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2022-10-05 17:00:00 9999999995-22-002944 333-267627 221297024 33 2024
2022-10-03 CORRESP filename1.htm 0001493152-22-027456 12150
2022-09-30 UPLOAD filename1.pdf 0000000000-22-010810 40493
2022-09-27 S-1 forms-1.htm 0001493152-22-026848 333-267627 221267097 33 6728361 1 1
2022-09-20 8-K form8-k.htm 7.01,9.01 0001493152-22-026315 000-19041 221252122 34 274514 1 1
2022-08-15 10-Q form10-q.htm 0001493152-22-022959 000-19041 221166601 34 3949264 1 1
2022-07-29 8-K form8-k.htm 1.01,3.02,9.01 0001493152-22-020769 000-19041 221121770 34 1052204 1 1
2022-05-24 8-K form8-k.htm 7.01,9.01 0001493152-22-014863 000-19041 22954032 34 252948 1 1
2022-05-16 10-Q form10-q.htm 0001493152-22-013812 000-19041 22929295 34 3469760 1 1
2022-05-09 8-K form8-k.htm 7.01,9.01 0001493152-22-012447 000-19041 22903366 34 248751 1 1
2022-04-19 8-K form8-k.htm 5.03,7.01,9.01 0001493152-22-010296 000-19041 22833544 34 1340877 1 1
2022-04-05 8-K form8-k.htm 7.01,9.01 0001493152-22-009113 000-19041 22805236 34 255686 1 1
2022-04-01 10-K form10-k.htm 0001493152-22-008634 000-19041 22795434 34 4680785 1 1
2022-04-01 NT 10-K formnt10-k.htm 0001493152-22-008624 000-19041 22795284 34 30794
2022-01-18 DEF 14C formdef14c.htm 0001493152-22-001377 000-19041 22533458 34 75047
2021-12-30 8-K form8-k.htm 1.01,3.02,3.03,4.01,5.03,9.01 0001493152-21-032849 000-19041 211533185 34 359066 1 1
2021-12-21 PRE 14C formpre14c.htm 0001493152-21-032120 000-19041 211506932 34 75507
2021-11-16 8-K form8-k.htm 7.01,9.01 0001493152-21-028857 000-19041 211414129 34 236695 1 1
2021-11-15 10-Q form10-q.htm 0001493152-21-028624 000-19041 211411000 34 3933288 1 1
2021-10-28 424B3 form424b3.htm 0001493152-21-026562 333-259290 211354925 33 2771115
2021-10-27 8-K form8-k.htm 1.01,3.03,5.03,9.01 0001493152-21-026413 000-19041 211350934 34 3094381 1 1
2021-09-22 8-K form8-k.htm 7.01,9.01 0001493152-21-023322 000-19041 211268223 34 12075485 1 1
2021-09-21 424B3 form424b3.htm 0001493152-21-023232 333-259290 211265653 33 1124099
2021-09-16 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-09-16 17:00:00 9999999995-21-003562 333-259290 211259173 33 1941
2021-09-14 CORRESP filename1.htm 0001493152-21-022692 11424
2021-09-13 S-1/A forms1-a.htm 0001493152-21-022543 333-259290 211249787 33 129293
2021-09-10 UPLOAD filename1.pdf 0000000000-21-011022 40396
2021-09-03 S-1 forms-1.htm 0001493152-21-021947 333-259290 211235535 33 5925166 1 1
2021-08-17 8-K form8-k.htm 7.01,9.01 0001493152-21-020366 000-19041 211181005 34 245420 1 1
2021-08-16 10-Q form10-q.htm 0001493152-21-019947 000-19041 211174842 34 4764500 1 1
2021-08-05 8-K form8-k.htm 7.01,9.01 0001493152-21-018676 000-19041 211146396 34 59980
2021-07-15 8-K form8-k.htm 7.01,9.01 0001493152-21-016887 000-19041 211091705 34 57276
2021-06-29 8-K form8-k.htm 7.01,9.01 0001493152-21-015478 000-19041 211055719 34 53954
2021-06-24 8-K form8-k.htm 1.01,2.01,3.02,7.01 0001493152-21-015149 000-19041 211040565 34 285802
2021-06-21 DEF 14C formdef14c.htm 0001493152-21-014750 000-19041 211027156 34 689321
2021-06-09 8-K form8-k.htm 7.01,9.01 0001493152-21-013867 000-19041 211004018 34 52175
2021-06-07 PRE 14C formpre14c.htm 0001493152-21-013740 000-19041 21999686 34 689514
2021-05-27 8-K form8-k.htm 7.01,9.01 0001493152-21-013023 000-19041 21968575 34 58076
2021-05-18 8-K form8-k.htm 7.01,9.01 0001493152-21-012056 000-19041 21933843 34 67278
2021-05-17 10-Q form10-q.htm 0001493152-21-011784 000-19041 21929711 34 1747097 1
2021-05-13 8-K form8-k.htm 7.01,9.01 0001493152-21-011212 000-19041 21917344 34 55229
2021-03-26 8-K form8-k.htm 1.01,8.01,9.01 0001493152-21-006903 000-19041 21776465 34 55389
2021-03-11 10-K form10-k.htm 0001493152-21-005816 000-19041 21733688 34 2207643 1
2021-02-23 8-K form8-k.htm 7.01,9.01 0001493152-21-004560 000-19041 21663141 34 60208
2021-02-19 8-K form8-k.htm 7.01,9.01 0001493152-21-004316 000-19041 21652055 34 59174
2021-02-17 8-K form8-k.htm 7.01,9.01 0001493152-21-004102 000-19041 21642570 34 61041
2020-12-30 8-K form8-k.htm 7.01,9.01 0001493152-20-024525 000-19041 201424075 34 53667
2020-12-10 8-K form8-k.htm 7.01,9.01 0001493152-20-023226 000-19041 201379373 34 51241
2020-11-23 8-K form8-k.htm 7.01,9.01 0001493152-20-022235 000-19041 201336124 34 42392
2020-11-13 8-K form8k.htm 7.01,9.01 0001493152-20-021231 000-19041 201309398 34 43813
2020-11-12 10-Q form10-q.htm 0001493152-20-020984 000-19041 201303064 34 1702466 1
2020-10-26 8-K form8-k.htm 1.01,7.01,9.01 0001493152-20-019912 000-19041 201258950 34 163445
2020-10-09 8-K form8-k.htm 7.01,9.01 0001493152-20-019184 000-19041 201232032 34 40731
2020-09-30 8-K form8-k.htm 7.01,9.01 0001493152-20-018612 000-19041 201212255 34 42499
2020-09-30 8-K form8-k.htm 1.01,2.03,3.02,9.01 0001493152-20-018577 000-19041 201210580 34 50749
2020-09-30 3 xslF345X02/ownership.xml 0001493152-20-018575 4320
2020-09-25 8-K form8-k.htm 1.01,2.03,3.02,9.01 0001493152-20-018313 000-19041 201196764 34 341285
2020-09-25 D xslFormDX01/primary_doc.xml 06b 0001493152-20-018310 021-376362 201196754 33 6352
2020-09-14 8-K form8-k.htm 7.01,9.01 0001493152-20-017684 000-19041 201172189 34 1534477
2020-09-01 8-K form8-k.htm 7.01,9.01 0001493152-20-017047 000-19041 201153216 34 44206
2020-08-24 8-K form8-k.htm 1.01,3.02,7.01,9.01 0001493152-20-016581 000-19041 201125037 34 81354
2020-08-13 10-Q form10-q.htm 0001493152-20-015420 000-19041 201097093 34 1379278 1
2020-06-30 8-K form8-k.htm 8.01,9.01 0001493152-20-012203 000-19041 201000288 34 47292
2020-05-14 10-Q form10-q.htm 0001493152-20-008610 000-19041 20875410 34 1280301 1
2020-04-22 8-K form8-k.htm 1.01,3.02,9.01 0001493152-20-006879 000-19041 20806591 34 68285
2020-03-17 8-K form8-k.htm 7.01,8.01,9.01 0001493152-20-004109 000-19041 20719221 34 4506149
2020-03-13 8-K form8k.htm 1.01,9.01 0001493152-20-003854 000-19041 20710603 34 134640
2020-03-11 S-8 forms-8.htm 0001493152-20-003708 333-237078 20704830 33 191020
2020-02-27 4 xslF345X03/ownership.xml 0001493152-20-003054 5590
2020-02-27 8-K form8-k.htm 1.01,2.03 0001493152-20-003044 000-19041 20658357 34 57742
2020-02-21 3 xslF345X02/ownership.xml 0001493152-20-002825 8185
2020-02-21 10-K form10-k.htm 0001493152-20-002791 000-19041 20637310 34 1359882 1
2020-02-19 8-K/A form8-ka.htm 2.01,9.01 0001493152-20-002688 000-19041 20627382 34 429311
2019-12-23 8-K form8-k.htm 1.01,2.01,3.02,4.01,5.01,5.06,9.01 0001493152-19-019583 000-19041 191304010 34 1044201
2019-11-12 10-Q form10-q.htm 0001493152-19-016803 000-19041 191205900 34 1084112 1
2019-09-05 8-K form8-k.htm 1.01,3.02 0001493152-19-013708 000-19041 191076121 34 151048
2019-08-05 10-Q form10-q.htm 0001493152-19-011579 000-19041 19997461 34 874686 1
2019-05-14 10-Q form10-q.htm 0001493152-19-006989 000-19041 19820356 34 831615 1
2019-03-28 10-K form10-k.htm 0001493152-19-004064 000-19041 19709871 34 979179 1
2019-02-20 8-K form8-k.htm 4.01,9.01 0001493152-19-002286 000-19041 19616584 34 46560
2018-10-29 10-Q form10-q.htm 0001493152-18-014906 000-19041 181142763 34 841723 1
2018-09-10 10-Q form10-q.htm 0001493152-18-013035 000-19041 181061575 34 868994 1
2018-08-29 10-Q form10-q.htm 0001493152-18-012678 000-19041 181042917 34 765728 1
2018-08-27 10-K form10-k.htm 0001493152-18-012599 000-19041 181038079 34 1133760 1
2018-08-22 10-Q form10-q.htm 0001493152-18-012452 000-19041 181031381 34 878855 1
2018-08-20 10-Q form10-q.htm 0001493152-18-012270 000-19041 181027004 34 901739 1
2018-08-17 10-Q form10-q.htm 0001493152-18-012205 000-19041 181024703 34 831019 1
2018-08-07 10-K form10-k.htm 0001493152-18-011033 000-19041 18995838 34 1207263 1
2018-07-20 10-Q form10-q.htm 0001493152-18-010260 000-19041 18961947 34 861130 1
2018-07-16 10-Q form10q.htm 0001493152-18-010016 000-19041 18953956 34 878665 1
2018-06-29 8-K form8-k.htm 4.01,9.01 0001493152-18-009406 000-19041 18926918 34 129382
2016-08-12 NT 10-Q LATE NOTIFICATION 0001295345-16-000608 000-19041 161827032 34 6761
2016-05-26 10-Q FORM 10-Q FOR THE PERIOD ENDED MARCH 31, 2016 0001295345-16-000591 000-19041 161676855 34 579587 1
2016-05-16 NT 10-Q LATE NOTIFICATION 0001295345-16-000567 000-19041 161652368 34 6738
2016-04-14 10-K FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 2015 0001295345-16-000517 000-19041 161572458 34 747328 1
2016-03-30 NT 10-K LATE NOTIFICATION 0001295345-16-000467 000-19041 161536855 34 6670
2015-11-23 10-Q FORM 10-Q FOR THE PERIOD ENDED SEPTEMBER 30, 2015 0001295345-15-000368 000-19041 151250536 34 625795 1
2015-11-16 NT 10-Q LATE NOTIFICATION 0001295345-15-000345 000-19041 151233929 34 6510
2015-08-19 10-Q FORM 10-Q FOR THE PERIOD ENDED JUNE 30, 2015 0001295345-15-000236 000-19041 151064290 34 558496 1
2015-08-14 NT 10-Q LATE NOTIFICATION 0001295345-15-000220 000-19041 151053888 34 6528
2015-08-04 8-K maba08032015.htm 1.01,3.02,9.01 0001295345-15-000191 000-19041 151023432 34 38799
2015-06-12 DEF 14C DEFINITIVE INFORMATION STATEMENT 0001295345-15-000176 000-19041 15927143 34 30650
2015-06-01 PRE 14C PRELIMINARY INFORMATION STATEMENT 0001295345-15-000154 000-19041 15903818 34 30671
2015-05-27 8-K CURRENT REPORT 5.02 0001295345-15-000149 000-19041 15891564 34 7653
2015-05-14 10-Q FORM 10-Q FOR THE PERIOD ENDED MARCH 31, 2015 0001295345-15-000125 000-19041 15862424 34 640336 1
2015-04-07 10-K FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 2014 0001295345-15-000084 000-19041 15755515 34 807749 1
2015-03-31 NT 10-K LATE NOTIFICATION 0001295345-15-000079 000-19041 15737880 34 6506
2014-11-14 10-Q FORM 10-Q FOR THE PERIOD ENDED SEPTEMBER 30, 2014 0000856984-14-000007 000-19041 141223096 34 627305 1
2014-08-19 10-Q FORM 10-Q FOR THE PERIOD ENDED JUNE 30, 2014 0001295345-14-000223 000-19041 141052021 34 613290 1
2014-08-14 NT 10-Q LATE NOTIFICATION 0001295345-14-000216 000-19041 141041128 34 6547
2014-05-12 10-Q maba03312014.htm 0001295345-14-000123 000-19041 14834539 34 488666 1
2014-05-12 10-K FORM 10-K FOR THE YEAR 2013 0001295345-14-000118 000-19041 14833894 34 673776 1
2014-04-14 10-Q FORM 10-Q FOR THE PERIOD ENDED SEPTEMBER 30, 2013 0001295345-14-000079 000-19041 14762020 34 509915 1
2014-04-14 10-Q FORM 10-Q FOR THE PERIOD ENDED JUINE 30, 2014 0001295345-14-000077 000-19041 14762012 34 502909 1
2014-04-14 10-Q FOR 10-Q FOR THE PERIOD ENDED MARCH 31, 2013 0001295345-14-000075 000-19041 14761987 34 489986 1
2014-02-26 10-K ANNUAL REPORT FOR THE YEAR ENDED DECEMBER 31, 2012 0001295345-14-000032 000-19041 14642982 34 678467 1
2014-01-31 10-Q FORM 10-Q FOR THE PERIOD ENDED SEPTEMBER 30, 2012 0001295345-14-000015 000-19041 14561935 34 494132 1
2012-11-13 NT 10-Q LATE NOTIFICATION 0001295345-12-000099 000-19041 121197902 34 6581
2012-09-27 10-Q QUARTERLY REPORT FOR THE PERIOD ENDED JUNE 30, 2012 0001295345-12-000084 000-19041 121112415 34 473803 1
2012-08-14 NT 10-Q LATE NOTIFICATION 0001295345-12-000077 000-19041 121030236 34 6580
2012-05-21 10-Q QUARTERLY REPORT FOR THE PERIOD ENDED MARCH 31, 2012 0001295345-12-000060 000-19041 12857658 34 457933 1
2012-05-14 NT 10-Q ntmaba.htm 0001295345-12-000055 000-19041 12838432 34 6544
2012-04-12 10-K ANNUAL REPORT FOR THE YEAR ENDED DECEMBER 31, 2011 0001295345-12-000036 000-19041 12755558 34 655214 1
2012-03-29 NT 10-K nt_maba.htm 0001295345-12-000032 000-19041 12723208 34 6554
2011-11-14 10-Q QUARTERLY REPORT FOR THE PERIOD ENDED SEPTEMBER 30, 2011 0001295345-11-000196 000-19041 111202721 34 425947 1
2011-09-22 8-K CURRENT REPORT ON FORM 8-K 1.01,9.01 0001295345-11-000153 000-19041 111102843 34 144719
2011-08-24 10-Q QUARTERLY REPORT FOR THE PERIOD ENDED JUNE 30, 2011 0001295345-11-000143 000-19041 111053836 34 456732 1
2011-08-15 NT 10-Q maba_nt.htm 0001295345-11-000135 000-19041 111035524 34 6549
2011-05-23 10-Q QUARTERLY REPORT FOR THE PERIOD ENDED MARCH 31, 2011 0001295345-11-000079 000-19041 11864521 34 87990
2011-05-16 NT 10-Q maba_nt.htm 0001295345-11-000072 000-19041 11846055 34 6597
2011-04-13 10-K ANNUAL REPORT FOR THE YEAR ENDED DECEMBER 31, 2010 0001295345-11-000041 000-19041 11757331 34 236179
2011-03-31 NT 10-K maba_nt.htm 0001295345-11-000030 000-19041 11725452 34 6554
2011-03-23 8-K CURRENT REPORT 4.01,9.01 0001295345-11-000022 000-19041 11705898 34 11915
2010-11-12 10-Q QUARTERLY REPORT FOR THE PERIOD ENDED SEPTEMBER 30, 2010 0001295345-10-000082 000-19041 101184077 34 94157
2010-08-18 8-K CURRENT REPORT 5.01 0001295345-10-000065 000-19041 101025581 34 7437
2010-08-10 10-Q QUARTERLY REPORT FOR THE PERIOD ENDED JUNE 30, 2010 0001295345-10-000061 000-19041 101004745 34 94041
2010-05-13 10-Q QUARTERLY REPORT FOR THE PERIOD ENDED MARCH 31, 2010 0001295345-10-000047 000-19041 10826948 34 88224
2010-04-14 10-K ANNUAL REPORT FOR THE YEAR ENDED DECEMBER 31, 2009 0001295345-10-000034 000-19041 10748858 34 219812
2010-03-31 NT 10-K LATE NOTIFICATION 0001295345-10-000029 000-19041 10718403 34 7050
2009-11-13 10-Q QUARTERLY REPORT FOR THE PERIOD ENDED SEPTEMBER 30, 2009 0001295345-09-000085 000-19041 091182344 34 92626
2009-08-14 10-Q QUARTERLY REPORT FOR THE PERIOD ENDED JUNE 30, 2009 0001295345-09-000060 000-19041 091015714 34 91089
2009-05-20 10-Q QUARTERLY REPORT FOR THE PERIOD ENDED MARCH 31, 2009 0001295345-09-000047 000-19041 09842268 34 85165
2009-05-14 NT 10-Q mabaa_nt.htm 0001295345-09-000034 000-19041 09825843 34 7016
2009-04-08 10-K ANNUAL REPORT FOR THE YEAR ENDED DECEMBER 31, 2008 0000856984-09-000003 000-19041 09739883 34 226956
2009-04-08 5 PRIMARY DOCUMENT 0001262453-09-000001 4114
2009-03-31 NT 10-K abs_nt.htm 0001295345-09-000017 000-19041 09719075 34 7017
2008-11-13 10-Q FORM 10-Q FOR THE PERIOD ENDED SEPTEMBER 30, 2008 0001295345-08-000114 000-19041 081183497 34 92195
2008-09-19 10KSB/A AMENDED ANNUAL REPORT FOR THE YEAR ENDED DECEMBER 31, 2007 0001295345-08-000101 000-19041 081080178 34 211921
2008-09-04 DEF 14C DEFINITIVE INFORMATION STATEMENT 0001295345-08-000085 000-19041 081055727 34 26607
2008-08-12 10-Q QUARTERLY REPORT FOR THE PERIOD ENDED JUNE 30, 2008 0001295345-08-000069 000-19041 081010009 34 90638
2008-08-06 UPLOAD filename1.pdf 0000000000-08-039501 41019
2008-08-06 UPLOAD filename1.pdf 0000000000-08-039499 62277
2008-08-01 CORRESP filename1.htm 0001295345-08-000063 3356
2008-08-01 10KSB/A AMENDED ANNUAL REPORT FOR THE YEAR ENDED DECEMBER 31, 2008 0001295345-08-000062 000-19041 08986050 34 211131
2008-07-10 PRE 14C PRELIMINARY INFORMATION STATEMENT 0001295345-08-000048 000-19041 08946587 34 26501
2008-05-14 10-Q QUARTERLY REPORT FOR THE PERIOD ENDED MARCH 31, 2008 0001295345-08-000039 000-19041 08830354 34 87059
2008-03-26 10KSB ANNUAL REPORT FOR THE YEAR ENDED DECEMBER 31, 2007 0001295345-08-000020 000-19041 08712299 34 208926
2008-03-25 5 PRIMARY DOCUMENT 0001262453-08-000002 5228
2008-03-05 3 PRIMARY DOCUMENT 0001262453-08-000001 4007
2007-11-14 10QSB QUARTERLY REPORT FOR THE PERIOD ENDED SEPTEMBER 30, 2007 0001295345-07-000133 000-19041 071240825 34 88207
2007-08-14 10QSB QUARTERLY REPORT FOR THE PERIOD ENDED JUNE 30, 2007 0001295345-07-000094 000-19041 071051968 34 89089
2007-07-09 UPLOAD NO FURTHER COMMENTS LETTER 07/09/07; (HOWARD/TLJ) 0000000000-07-033123 16296
2007-06-27 CORRESP filename1.htm 0000856984-07-000007 3161
2007-06-27 8-K CURRENT REPORT 4.01 0000856984-07-000005 000-19041 07943704 34 10511
2007-06-22 UPLOAD FY 2006 FORM 10-KSB; FILE NO. 000-19041; COMMENT LETTER 06/22/07; (HOWARD/JENKIN 0000000000-07-030822 38474
2007-05-14 10QSB QUARTERLY REPORT FOR THE PERIOD ENDED MARCH 31, 2007 0001295345-07-000059 000-19041 07847623 34 85151
2007-03-30 10KSB ANNUAL REPORT FOR THE YEAR ENDED DECEMBER 31, 2006 0001295345-07-000025 000-19041 07730809 34 214962
2006-11-14 10QSB QUARTERLY REPORT FOR THE PERIOD ENDED SEPTEMBER 30, 2006 0001295345-06-000151 000-19041 061212635 34 90755
2006-08-14 10QSB QUARTERLY REPORT FOR THE PERIOD ENDED JUNE 30, 2006 0001295345-06-000095 000-19041 061028514 34 94268
2006-05-12 10QSB QUARTERLY REPORT FOR THE PERIOD ENDED MARCH 31, 2006 0000856984-06-000031 000-19041 06832766 34 91589
2006-03-28 10KSB ANNUAL REPORT FOR THE YEAR ENDED DECEMBER 31, 2005 0000856984-06-000028 000-19041 06714834 34 228301
2006-03-02 10QSB QUARTERLY REPORT ON FORM 10-QSB FOR THE PERIOD ENDED SEPTEMBER 30, 2005 0000856984-06-000026 000-19041 06658964 34 101271
2006-03-02 10QSB QUARTERLY REPORT ON FORM 10-QSB FOR THE PERIOD ENDED JUNE 30, 2005 0000856984-06-000025 000-19041 06658801 34 99923
2006-03-02 10QSB QUARTERLY REPORT ON FORM 10-QSB FOR THE PERIOD ENDED MARCH 31, 2005 0000856984-06-000024 000-19041 06658655 34 90936
2006-03-01 10KSB ANNUAL REPORT ON FORM 10-KSB FOR THE YEAR ENDED DECEMBER 31, 2004 0000856984-06-000022 000-19041 06655615 34 240718
2006-03-01 10QSB QUARTERLY REPORT ON FORM 10-QSB FOR THE PERIOD ENDED SEPTEMBER 30, 2004 0000856984-06-000020 000-19041 06654996 34 101605
2006-03-01 10QSB QUARTERLY REPORT ON FORM 10-QSB FOR THE PERIOD ENDED JUNE 30, 2004 0000856984-06-000018 000-19041 06654122 34 100967
2006-02-28 10QSB QUARTERLY REPORT ON FORM 10-QSB FOR THE PERIOD ENDED MARCH 31, 2004 0000856984-06-000016 000-19041 06651336 34 93177
2006-02-28 10KSB ANNUAL REPORT ON FORM 10-KSB FOR THE YEAR ENDED DECEMBER 31, 2003 0000856984-06-000014 000-19041 06650549 34 245190
2006-02-28 10QSB QUARTERLY REPORT ON FORM 10-QSB FOR THE PERIOD ENDED SEPTEMBER 30, 2003 0000856984-06-000012 000-19041 06649741 34 100771
2006-02-27 10QSB QUARTERLY REPORT ON FORM 10-QSB FOR THE PERIOD ENDED JUNE 30, 2003 0000856984-06-000010 000-19041 06646636 34 100653
2006-02-27 10QSB QUARTERLY REPORT ON FORM 10-QSB FOR THE PERIOD ENDED MARCH 31, 2003 0000856984-06-000008 000-19041 06646092 34 92996
2006-02-16 10KSB mbaa.htm 0000856984-06-000004 000-19041 06624702 34 1260398
2006-02-15 10QSB QUARTERLY REPORT FOR THE PERIOD ENDED SEPTEMBER 30, 2002 0000856984-06-000002 000-19041 06620823 34 109776
2002-09-20 8-K FORM 8-K (09/17/02) 3,5,7 0000910680-02-000793 000-19041 02769252 143075
2002-08-19 10-Q FORM 10-Q 0000910680-02-000734 000-19041 02742644 107444
2002-08-15 8-K/A FORM 8-K/A - 8/5/02 4 0000910680-02-000723 000-19041 02740030 6783
2002-08-15 NT 10-Q FORM 12B-25 (06/30/02) 0000910680-02-000721 000-19041 02740011 9087
2002-08-09 8-K FORM 8-K (08/05/02) 4 0000910680-02-000666 000-19041 02724866 6754
2002-05-15 10-Q FORM 10Q FOR PERIOD ENDING 03/31/2002 0000856984-02-000012 000-19041 02649965 93903
2002-05-07 8-K a8k0506main.txt 5,7 0000856984-02-000009 000-19041 02635714 6086
2002-03-28 10-K a10kmain.txt 0000856984-02-000007 000-19041 02591442 323559
2002-01-23 8-K a8kmain20020114.txt 5,7 0000856984-02-000004 000-19041 02514783 32901
2002-01-09 8-K a8kmain.txt 5,7 0000856984-02-000002 000-19041 2504893 30609
2001-11-14 10-Q a20010930.txt 0000856984-01-500004 000-19041 1790368 95572
2001-09-18 8-K AMERICAN BIOGENETIC SCIENCES INC. 5,7 0000950135-01-502842 000-19041 1739810 364385
2001-09-13 SC 13D/A SC 13D/A 0000912057-01-532125 005-45379 1736450 106918
2001-08-13 10-Q AMERICAN BIOGENETIC SCIENCES 0000950135-01-502461 000-19041 1707047 98761
2001-07-13 8-K AMERICAN BIOGENETICS SCIENCES INC. 2,7 0000950135-01-502015 000-19041 1680750 140796
2001-05-15 10-Q AMERICAN BIOGENETIC SCIENCES, INC 0000950135-01-501262 000-19041 1635425 85780
2001-05-15 DEF 14A AMERICAN BIOGENETIC SCIENCES INC. 0000950135-01-501241 000-19041 1634345 103780
2001-04-30 10-K405/A AMERICAN BIOGENETICS SCIENCES, INC. 0000950135-01-500888 000-19041 1616817 140621
2001-04-20 PRE 14A AMERICAN BIOGENETIC SCIENCE, INC. 0000950135-01-500663 000-19041 1607398 104040
2001-04-02 10-K405 AMERICAN BIOGENETICS SCIENCES INC. 0000950135-01-001098 000-19041 1588901 252170
2001-01-16 8-K AMERICAN BIOGENETICS SCIENCES, INC 5,7 0000950135-01-000106 000-19041 1509657 9652
2000-11-13 10-Q 3RD QTR 9/30/00 0000856984-00-000004 000-19041 758220 75479
2000-09-12 S-8 AMERICAN BIOGENETIC SCIENCES, INC. 0000950135-00-004308 333-45644 721473 50590
2000-08-10 10-Q 2ND QTR 6/30/00 0000856984-00-000003 000-19041 691589 77789
2000-07-27 8-K 0001.txt 5 0000856984-00-000002 000-19041 680210 3430
2000-06-27 SC 13D/A SCHEDULE 13D/A 0000912057-00-029925 005-45379 661817 19857
2000-05-16 10-Q/A 1ST QTR 3/31/00 0000950135-00-002910 000-19041 637294 73432
2000-05-12 10-Q 1ST QTR 3/31/00 0000856984-00-000001 000-19041 630003 72670
2000-05-02 S-3 AMERICAN BIOGENETICS SCIENCES, INC. 0000950135-00-002471 333-36116 617225 70945
2000-05-02 S-3 AMERICAN BIOGENETICS SCIENCES, INC. 0000950135-00-002469 333-36110 617192 76084
2000-05-02 S-3 AMERICAN BIOGENETICS SCIENCES, INC. 0000950135-00-002468 333-36106 617155 94654
2000-05-01 DEF 14A AMERICAN BIOGENETIC SCIENCES INC 0000950135-00-002432 000-19041 615512 101465
2000-04-13 PRE 14A AMERICAN BIOGENETICS SCIENCES INC 0000950135-00-002145 000-19041 600761 102548
2000-04-12 SC 13D/A AMERICAN BIOGENETIC SCIENCES, INC. 0000950135-00-002120 005-45379 599246 143897
2000-03-30 10-K405 AMERICAN BIOGENETIC SCIENCES, INC. 0000950135-00-001901 000-19041 588549 397702
2000-03-07 8-K AMERICAN BIOGENETIC SCIENCES INC 5,7 0000950135-00-001275 000-19041 562592 168854
2000-02-29 SC 13D SCHEDULE 13D 0000912057-00-008910 005-45379 556675 146851
2000-02-11 DEF 14A AMERICAN BIOGENETIC SCIENCES, INC. 0000950135-00-000660 000-19041 535339 48907
2000-02-08 SC 13D SC 13D 0000912057-00-004414 005-45379 526560 103660
2000-02-07 PRER14A AMERICAN BIOGENETIC SCIENCES, INC 0000950135-00-000408 000-19041 524674 47898
2000-02-07 SC 13D SC 13D 0000912057-00-004286 005-45379 525867 103661
2000-02-01 SC 13D/A AMENDMENT NO. 1 TO SCHEDULE 13D 0000910680-00-000045 005-45379 519126 51306
2000-01-25 PRE 14A NOTICE AND PROXY 0000950135-00-000234 000-19041 512920 44389
1999-12-20 S-8 FORM S-8 OF AMERICAN BIOGENETIC SCIENCES, INC. 0000910680-99-000489 333-93071 99777326 43332
1999-11-12 10-Q 3RD QTR 9/30/99 0000856984-99-000003 000-19041 99749571 73010
1999-09-01 DEF 14A AMERICAN BIOGENETIC SCIENCES, INC. SCHEDULE 14A 0000910680-99-000278 000-19041 99704740 48237
1999-08-16 PRE 14A AMERICAN BIOGENETIC SCIENCES, INC. SCHEDULE 14C 0000910680-99-000262 000-19041 99693025 48124
1999-08-13 10-Q 2ND QTR 6/30/99 0000856984-99-000002 000-19041 99689424 76289
1999-07-06 424B3 AMERICAN BIOGENETIC SCIENCES, INC. 424B3 0000910680-99-000230 333-69735 99659460 49566
1999-06-22 S-3/A AMENDMENT NO. 2 TO FORM S-3 REG. SMT. 0000910680-99-000213 333-69735 99650244 71139
1999-05-14 DEFR14A AMERICAN BIOGENETIC SCIENCES, INC. REVISED PROXY 0000910680-99-000178 000-19041 99622048 82454
1999-05-14 10-Q 1ST QTR 3/31/99 0000856984-99-000001 000-19041 99623247 65979
1999-04-30 DEF 14A AMERICAN BIOGENETIC SCIENCES, INC.PROXY 0000910680-99-000166 000-19041 99607647 80588
1999-04-30 10-K/A AMERICAN BIOGENETIC SCIENCES, INC. FORM 10-K/A 0000910680-99-000164 000-19041 99606818 31043
1999-04-15 S-3/A AMENDMENT NO. 1 TO FORM S-3 0000910680-99-000148 333-69735 99594815 71843
1999-03-31 10-K AMERICAN BIOGENETIC FORM 10-K 0000910680-99-000135 000-19041 99584159 295618
1999-02-25 10-Q/A AMENDMENT NO. 1 TO FORM 10-Q 0000910680-99-000092 000-19041 99550367 20765
1998-12-24 S-3 AMERICAN BIOGENETIC SCEIENCES S-3 0000910680-98-000419 333-69735 98775712 105573
1998-11-25 SC 13D SCHEDULE 13D 0000910680-98-000400 005-45379 98759642 77207
1998-11-13 10-Q 3RD QTR 9/30/98 0000856984-98-000010 000-19041 98749270 78301
1998-10-14 DEFS14A DEFINITIVE PROXY STATEMENT 0000910680-98-000363 000-19041 98725437 55015
1998-09-21 PRES14A AMERICAN BIOGENETIC SCIENCES, INC. PROXY 0000910680-98-000340 000-19041 98712477 51402
1998-08-13 10-Q 2ND QTR 6/30/98 0000856984-98-000008 000-19041 98685296 75553
1998-08-07 S-3/A AMERICAN BIOGENETIC SCIENCES, INC. S-3/A 0000910680-98-000298 333-59345 98679152 97928
1998-07-29 S-3 AMERICAN BIOGENETIC SCIENCES, INC. 0000950135-98-004402 333-60117 98673410 87276
1998-07-17 S-8 AMERICAN BIOGENEICS SCIENCES, INC. S-8 0000910680-98-000288 333-59351 98668234 41918
1998-07-17 S-3 AMERICAN BIOGENEICS SCIENCES, INC. S-3 0000910680-98-000287 333-59345 98668208 102942
1998-06-03 8-K DATE OF REPORT: MAY 20, 1998 5,7 0000910680-98-000241 000-19041 98641672 281576
1998-05-15 DEF 14A DEFINITIVE PROXY 0000910680-98-000210 000-19041 98622704 66663
1998-05-15 10-Q/A 0000856984-98-000005 0000856984-98-000005 000-19041 98624139 56364
1998-05-15 10-Q 10 Q FIRST QTR 3/31/98 0000856984-98-000004 000-19041 98621690 56368
1998-04-30 10-K/A AMENDMENT NO.1 TO FYE 12/31/97 FORM 10-K 0000910680-98-000191 000-19041 98605468 33251
1998-04-28 8-K 0000856984-98-000003 5 0000856984-98-000003 000-19041 98602128 8734
1998-03-26 10-K 0000856984-98-000002 0000856984-98-000002 000-19041 98574074 208638
1998-02-10 SC 13G/A A. ROACH SCHEDULE 13G AMENDMENT NO.6 0000910680-98-000068 005-45379 98529750 11577
1997-11-14 10-Q 10 Q THIRD QTR. 9/30/97 0000856984-97-000010 000-19041 97717732 51063
1997-10-20 8-K 0000856984-97-000009 5 0000856984-97-000009 000-19041 97698185 3484
1997-08-11 10-Q 10 Q SECOND QTR. 6/30/97 0000856984-97-000008 000-19041 97655905 57003
1997-05-15 DEF 14A DEFINITIVE PROXY 0000910680-97-000162 000-19041 97606767 45030
1997-05-15 10-Q 10 Q FIRST QTR. 3/31/97 0000856984-97-000006 000-19041 97607884 52441
1997-04-30 10-K/A AMENDMENT TO ANNUAL REPORT 0000910680-97-000150 000-19041 97591222 85977
1997-03-28 10-K 0000856984-97-000003 0000856984-97-000003 000-19041 97567694 193317
1997-02-24 SC 13G/A A. ROACH SCHEDULE 13G AMENDMENT NO.5 0000910680-97-000092 005-45379 97542334 10890
1996-12-23 S-3/A AMENDMENT NO.1 ON FORM S-3 (FILE NO.333-14447) 0000910680-96-000379 333-14447 96684575 83100
1996-11-18 10-Q/A 0000856984-96-000007 0000856984-96-000007 000-19041 96668136 52047
1996-11-13 10-Q 10 Q SECOND QTR.9/30/96 0000856984-96-000004 000-19041 96662370 36300
1996-10-18 S-3 FORM S-3 FOR 3,068,118 SHARES OF COMMON STOCK 0000910680-96-000309 333-14447 96645384 99174
1996-10-17 424B3 D.H.BLAIR 424B3 PROSPECTUS 0000910680-96-000308 333-13623 96644789 50760
1996-10-17 424B3 GLADSTONE PARTNERS 424B3 PROSPECTUS 0000910680-96-000307 333-13619 96644783 50754
1996-10-17 424B3 THE SAGE GROUP 424B3 PROSPECTUS 0000910680-96-000306 333-13615 96644780 50914
1996-10-07 S-3 D.H. BLAIR FORM S-3 0000910680-96-000287 333-13623 96640371 81144
1996-10-07 S-3 GLADSTONE PARTNERS FORM S-3 0000910680-96-000286 333-13619 96640367 81635
1996-10-07 S-3 THE SAGE GROUP FORM S-3 0000910680-96-000285 333-13615 96640364 81026
1996-10-07 8-K PLACEMENT OF $9MM OF 7% COV. DEBENTURES 2 0000910680-96-000284 000-19041 96640359 123173
1996-08-13 10-Q 10 Q SECOND QTR.6/30/96 0000856984-96-000003 000-19041 96611066 48561
1996-08-02 S-8 AMER. BIOGENETIC SCIENCES FORM S-8 0000910680-96-000194 333-09473 96603164 62591
1996-05-14 10-Q 10 Q FIRST QTR. 3/31/96 0000856984-96-000002 000-19041 96563814 44167
1996-02-14 SC 13G/A AMENDED SCHEDULE 13G 0000874963-96-000002 005-45379 96518410 17231

Latest XBRL company facts

One latest value per concept from companyfacts (202 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 15.03M 2026-11-12 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
dei EntityPublicFloat Entity Public Float USD 1.56M 2025-06-30 2025 FY 10-K 2026-03-30 0001493152-26-013513
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 159,620 2020-12-31 2020 FY 10-K 2021-03-11 0001493152-21-005816
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 135,616 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap AccountsPayableTrade Accounts Payable, Trade (Deprecated 2009-01-31) USD 4,750 2014-03-31 2014 Q1 10-Q 2014-05-12 0001295345-14-000123
us-gaap AccountsPayableTradeCurrent Accounts Payable, Trade, Current USD 551 2018-09-30 2018 Q3 10-Q 2018-10-29 0001493152-18-014906
us-gaap AccountsPayableTradeCurrentAndNoncurrent Accounts Payable, Trade USD 19,857 2016-03-31 2016 Q1 10-Q 2016-05-26 0001295345-16-000591
us-gaap AccountsReceivableGrossCurrent Accounts Receivable, before Allowance for Credit Loss, Current USD 338,923 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 308,923 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 73,065 2016-12-31 2016 FY 10-K 2018-08-07 0001493152-18-011033
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 5.53M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 46,191 2012-06-30 2012 Q2 10-Q 2012-09-27 0001295345-12-000084
us-gaap AdjustmentForAmortization Amortization USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-022888
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 6,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001230
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 2,020 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-27 0001493152-24-011551
us-gaap AdvancesToAffiliate Advances to Affiliate USD 41,282 2015-06-30 2015 Q2 10-Q 2015-08-19 0001295345-15-000236
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 1,258 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001230
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 30,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 84,082 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001230
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 18,028 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-022888
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 8.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap Assets Assets USD 1.75M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap AssetsCurrent Assets, Current USD 519,108 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap CapitalizedComputerSoftwareAccumulatedAmortization Capitalized Computer Software, Accumulated Amortization USD 223,390 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap CapitalizedComputerSoftwareAmortization1 Capitalized Computer Software, Amortization USD 18,616 2024-04-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001493152-24-031878
us-gaap CapitalizedComputerSoftwareGross Capitalized Computer Software, Gross USD 223,390 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap CapitalizedComputerSoftwareImpairments1 Capitalized Computer Software, Impairments USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-022888
us-gaap CapitalizedComputerSoftwareNet Capitalized Computer Software, Net USD 18,616 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013513
us-gaap CapitalizedContractCostAccumulatedAmortization Capitalized Contract Cost, Accumulated Amortization USD 0 2020-12-31 2020 FY 10-K 2021-03-11 0001493152-21-005816
us-gaap CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers Capitalized Software Development Costs for Software Sold to Customers USD 93,079 2023-12-31 2023 FY 10-K 2024-03-27 0001493152-24-011551
us-gaap Cash Cash USD 0 2016-03-31 2016 Q1 10-Q 2016-05-26 0001295345-16-000591
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 190,464 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 0 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-23 0001295345-15-000368
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 190,464 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -445,693 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap CashPeriodIncreaseDecrease Cash, Period Increase (Decrease) USD 0 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-26 0001295345-16-000591
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 944,854 2024-09-30 2024 Q3 10-Q 2024-11-13 0001493152-24-045058
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 900.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 15.03M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 15.03M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap CommonStockShareSubscribedButUnissuedSubscriptionsReceivable Common Stock, Share Subscribed but Unissued, Subscriptions Receivable USD 648,000 2015-12-31 2016 FY 10-K 2018-08-07 0001493152-18-011033
us-gaap CommonStockValue Common Stock, Value, Issued USD 1,503 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 100,000 2021-12-31 2022 FY 10-K 2023-03-29 0001493152-23-009477
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 20,000 2025-12-31 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 20,000 2025-12-31 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap CostOfRevenue Cost of Revenue USD 724,297 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap CostsAndExpenses Costs and Expenses USD 10,325 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-14 0001493152-19-006989
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 20,000 2025-01-01 2025-12-31 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 421,827 2025-01-01 2025-12-31 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD 126,548 2025-01-01 2025-12-31 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap DebtDefaultLongtermDebtAmount Debt Instrument, Debt Default, Amount USD 49,165 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013513
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 0.3 2025-12-31 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap DebtInstrumentConvertibleConversionPriceDecrease Debt Instrument, Convertible, Conversion Price, Decrease USD/shares 0.2 2024-03-04 2024 Q3 10-Q 2024-11-13 0001493152-24-045058
us-gaap DebtInstrumentDecreaseForgiveness Debt Instrument, Decrease, Forgiveness USD 12,000 2024-03-04 2024 Q3 10-Q 2024-11-13 0001493152-24-045058
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 440,000 2025-11-18 2025 FY 10-K 2026-03-30 0001493152-26-013513
us-gaap DebtInstrumentIncreaseAccruedInterest Debt Instrument, Increase, Accrued Interest USD 1.45M 2025-11-18 2025 FY 10-K 2026-03-30 0001493152-26-013513
us-gaap DebtInstrumentIncreaseDecreaseForPeriodNet Debt Instrument, Increase (Decrease), Net USD 806,000 2024-03-04 2024 Q1 10-Q 2024-05-13 0001493152-24-018786
us-gaap DebtInstrumentInterestRateDuringPeriod Debt Instrument, Interest Rate During Period pure 0.1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.1 2025-12-31 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap DebtInstrumentPeriodicPayment Debt Instrument, Periodic Payment USD 158,038 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013513
us-gaap DebtInstrumentRepurchaseAmount Debt Instrument, Repurchase Amount USD 1.57M 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013513
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 6,290 2022-06-30 2022 Q2 10-Q 2022-08-15 0001493152-22-022959
us-gaap DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD 37,830 2022-06-30 2022 Q2 10-Q 2022-08-15 0001493152-22-022959
us-gaap DeferredCompensationEquity Deferred Compensation Equity USD 6,968 2021-12-31 2022 Q3 10-Q 2022-11-14 0001493152-22-031462
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 84,082 2022-12-31 2023 FY 10-K 2024-03-27 0001493152-24-011551
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 818,220 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap DepositLiabilitiesAccruedInterest Deposit Liabilities, Accrued Interest USD 64,620 2016-03-31 2016 Q1 10-Q 2016-05-26 0001295345-16-000591
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 54,084 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 54,084 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap DividendsCommonStockStock Dividends, Common Stock, Stock USD 59,235 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-13 0001493152-25-022138
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 2,501 2020-09-30 2020 Q3 10-Q 2020-11-12 0001493152-20-020984
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.01 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.1 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-01 0001493152-22-008634
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.01 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-27 0001493152-24-011551
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.21 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 6,000 2022-12-31 2023 FY 10-K 2024-03-27 0001493152-24-011551
us-gaap ExtinguishmentOfDebtGainLossNetOfTax Extinguishment of Debt, Gain (Loss), Net of Tax USD 21,299 2020-01-01 2020-06-30 2021 Q2 10-Q 2021-08-16 0001493152-21-019947
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 378,587 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap FinitelivedIntangibleAssetsAcquired1 Finite-lived Intangible Assets Acquired USD 1.61M 2021-06-23 2024 Q3 10-Q 2024-11-13 0001493152-24-045058
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 1.61M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 1.23M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap GainLossOnRepurchaseOfDebtInstrument Gain (Loss) on Repurchase of Debt Instrument USD -479,940 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013513
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 1.15M 2025-01-01 2025-12-31 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 768,927 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap GrossProfit Gross Profit USD 1.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -119,021 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-10 0001493152-23-027470
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 54,440 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-28 0001641172-25-001230
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -190,815 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -56,808 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001493152-21-028624
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 118,313 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 59,255 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001493152-23-009477
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD 30,535 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001493152-21-028624
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -35,790 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities USD 6,975 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-23 0001295345-15-000368
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD 2,555 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 4,933 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 8,848 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-11 0001493152-21-005816
us-gaap IncreaseDecreaseInPrepaidExpensesOther Increase (Decrease) in Prepaid Expenses, Other USD 11,115 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-01 0001493152-22-008634
us-gaap IncrementalCommonSharesAttributableToConversionOfPreferredStock Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock shares 8.04M 2025-01-01 2025-12-31 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 1.52M 2022-09-30 2022 Q3 10-Q 2022-11-14 0001493152-22-031462
us-gaap InterestExpense Interest Expense USD 19,482 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 12,751 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap InterestPayableCurrent Interest Payable, Current USD 34,191 2022-06-30 2022 Q2 10-Q 2022-08-15 0001493152-22-022959
us-gaap InventoryNet Inventory, Net USD 35,790 2025-12-31 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 21,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap Liabilities Liabilities USD 247,114 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 1.75M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap LiabilitiesCurrent Liabilities, Current USD 247,114 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 96,218 2025-12-31 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap LitigationReserveCurrent Estimated Litigation Liability, Current USD 3,356 2021-03-31 2021 Q1 10-Q 2021-05-17 0001493152-21-011784
us-gaap LoansPayable Loans Payable USD 90,704 2025-12-31 2026 Q1 10-Q 2026-05-14 0001493152-26-022888
us-gaap LoansPayableCurrent Loans Payable, Current USD 85,571 2025-12-31 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap LongTermDebt Long-term Debt USD 329,181 2016-03-31 2016 Q1 10-Q 2016-05-26 0001295345-16-000591
us-gaap LongTermDebtAndCapitalLeaseObligations Long-term Debt and Lease Obligation USD 90,704 2025-12-31 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap LongTermLoansPayable Loans Payable, Noncurrent USD 96,218 2025-12-31 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 198,062 2019-09-30 2019 Q3 10-Q 2019-11-12 0001493152-19-016803
us-gaap MarketingExpense Marketing Expense USD 95,141 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-11 0001493152-21-005816
us-gaap NetCashProvidedByUsedInContinuingOperations Net Cash Provided by (Used in) Continuing Operations USD -14,875 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-14 0000856984-14-000007
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -110,704 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -37,119 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-27 0001493152-24-011551
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -334,989 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -119,021 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -69,620 2012-01-01 2012-12-31 2012 FY 10-K 2014-02-26 0001295345-14-000032
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 55,000 2020-12-31 2021 FY 10-K 2022-04-01 0001493152-22-008634
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap OperatingExpenses Operating Expenses USD 1.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -99,539 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 4.02M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap OtherAccountsPayableAndAccruedLiabilities Other Accounts Payable and Accrued Liabilities USD 14,875 2014-09-30 2014 Q3 10-Q 2014-11-14 0000856984-14-000007
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 850 2018-09-30 2018 Q3 10-Q 2018-10-29 0001493152-18-014906
us-gaap OtherIncome Other Income USD 82 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013513
us-gaap OtherLaborRelatedExpenses Other Labor-related Expenses USD 56,000 2012-01-01 2012-12-31 2012 FY 10-K 2014-02-26 0001295345-14-000032
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 13,682 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap OtherLoansPayableCurrent Other Loans Payable, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013513
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2014-02-26 0001295345-14-000032
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 7,987 2023-12-31 2023 FY 10-K 2024-03-27 0001493152-24-011551
us-gaap PaymentsForLoans Payments for Loans USD 14,262 2025-11-12 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap PaymentsForSoftware Payments for Software USD 37,119 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-27 0001493152-24-011551
us-gaap PaymentsOfDebtExtinguishmentCosts Payment for Debt Extinguishment or Debt Prepayment Cost USD 300,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013513
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 30,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-27 0001493152-24-011551
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.25 2023-12-31 2023 FY 10-K 2024-03-27 0001493152-24-011551
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 1.08M 2021-09-30 2021 Q3 10-Q 2021-11-15 0001493152-21-028624
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 1.08M 2021-09-30 2021 Q3 10-Q 2021-11-15 0001493152-21-028624
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 108 2021-09-30 2021 Q3 10-Q 2021-11-15 0001493152-21-028624
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 19,721 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 11,598 2020-12-31 2020 FY 10-K 2021-03-11 0001493152-21-005816
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 400,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-27 0001493152-24-011551
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 499,998 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013513
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 128,500 2022-03-01 2022-03-02 2022 Q1 10-Q 2022-05-16 0001493152-22-013812
us-gaap ProceedsFromLoans Proceeds from Loans USD 114,400 2025-11-12 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 968 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap ProceedsFromRepaymentsOfRelatedPartyDebt Proceeds from (Repayments of) Related Party Debt USD 55,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-21 0001493152-20-002791
us-gaap ProceedsFromShortTermDebt Proceeds from Short-term Debt USD 114,400 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013513
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 7,276 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap RelatedPartyTransactionDueFromToRelatedPartyCurrent Related Party Transaction, Due from (to) Related Party, Current USD 56,410 2015-12-31 2015 FY 10-K 2016-04-14 0001295345-16-000517
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 179,178 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-01 0001493152-22-008634
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 13,536 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap RepaymentsOfShortTermDebt Repayments of Short-term Debt USD 110,704 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 350,604 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -4.02M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 2.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap Revenues Revenues USD 0 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-26 0001295345-16-000591
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 454,974 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 5,664 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-29 0001493152-23-009477
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.763 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-29 0001493152-23-009477
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.002 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-29 0001493152-23-009477
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations shares 550,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 650,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 0 2025-01-01 2025-12-31 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 0 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-12 0001493152-23-016675
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 1.10M 2022-12-31 2023 FY 10-K 2024-03-27 0001493152-24-011551
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 1.10M 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013513
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 0.12 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-29 0001493152-23-009477
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0.04 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-13 0001493152-20-015420
us-gaap ShortTermBorrowings Short-term Debt USD 546,052 2023-12-31 2023 FY 10-K 2024-03-27 0001493152-24-011551
us-gaap ShorttermDebtAverageOutstandingAmount Short-term Debt, Average Outstanding Amount USD 146,548 2025-01-01 2025-12-31 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 1.51M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap StockholdersEquityOther Stockholders' Equity, Other USD 217 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-11 0001493152-21-005816
us-gaap StockIssued1 Stock Issued USD 1.61M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-29 0001493152-23-009477
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 76,923 2021-08-08 2021-08-10 2021 FY 10-K 2022-04-01 0001493152-22-008634
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 0 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-12 0001493152-23-016675
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 75,000 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 221,779 2021-07-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001493152-21-028624
us-gaap StockIssuedDuringPeriodValueDividendReinvestmentPlan Stock Issued During Period, Value, Dividend Reinvestment Plan USD 30,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-29 0001493152-23-009477
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 21,000 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 416,752 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013513
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 74,332 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-29 0001493152-23-009477
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 862,500 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-29 0001493152-23-009477
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 440,000 2024-02-19 2024 Q1 10-Q 2024-05-13 0001493152-24-018786
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 950,470 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013513
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 10,684 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 15.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 7.86M 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-01 0001493152-22-008634
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 15.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051468

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →